Table 1 Demographic and clinical characteristics of children with AOM
Characteristics | Category | Total (%) n = 62 | No of SP positive samples (%) | ||
|---|---|---|---|---|---|
MEF during AOM | NP/OP during AOM | NP/OP during PT visitc | |||
Age (yr) | 1–2 | 20 (32.3) | 6 (30.0) | 5 (25.0) | 5 (25.0) |
3–5 | 31 (50.0) | 10 (32.3) | 11 (35.5) | 5 (21.7) | |
≥6 | 11 (17.7) | 1 (9.1) | 1 (9.1) | 1 (10.0) | |
Sex | Male | 38 (61.3) | 13 (34.2) | 12 (31.6) | 8 (24.2) |
Female | 24 (38.7) | 4 (16.7) | 5 (20.8) | 3 (15.0) | |
Sibling possessing | No | 21 (33.9) | 6 (28.6) | 5 (23.8) | 4 (23.5) |
1 | 30 (48.4) | 11 (36.7) | 11 (36.7) | 7 (25.9) | |
≥2 | 11 (17.7) | 0 (0.0) | 1 (9.1) | 0 (0.0) | |
DCC/school attendance | 45 (72.6) | 12 (26.7) | 12 (26.7) | 7 (18.9) | |
Laterality | Unilateral | 25 (40.3) | 5 (20.0) | 5 (20.0) | 2 (9.1) |
Bilateral | 37 (59.7) | 12 (32.4) | 12 (32.4) | 9 (29.0) | |
Category of AOM | TF | 37 (59.7) | 10 (27.0) | 11 (29.7) | 7 (24.1) |
R | 6 (9.7) | 3 (50.0) | 1 (16.7) | 1 (16.7) | |
N | 19 (30.7) | 4 (21.1) | 5 (26.3) | 3 (16.7) | |
CRP (mg/L) (median, range)a | 2.27 (0.01–46.9) | 3.6 (0.15–12.0) | 4.8 (0.05–19.5) | NA | |
WBC (G/L) (median, range)b | 14.0 (5.4–33.0) | 20.4 (7.8–30.2) | 17.6 (7.8–30.2) | NA | |
Ongoing antibiotic therapy at the admission to hospital | No | 46 (74.2) | 15 (32.6) | 15 (32.6) | 10 (24.4) |
Yes | 16 (25.8) | 2 (12.5) | 2 (12.5) | 1 (8.3) | |
Antibiotic therapy at the hospital | AM/AMC | 11 (17.7) | 3 (27.3) | 1 (9.1) | 1 (11.1) |
CXM | 21 (33.9) | 4 (19.1) | 5 (23.8) | 4 (20.0) | |
CTX/CAZ | 28 (45.2) | 10 (35.7) | 11 (39.3) | 6 (26.1) | |
CLI | 2 (3.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Antipneumococcal vaccination | 13 (21.0) | 1 (7.7) | 0 (0.0) | 0 (0.0) | |
AntiHib vaccination | 58 (93.5) | 17 (29.3) | 17 (29.3) | 11 (22.5) | |